Connect With Europe’s Leading Obesity Experts
GLP-1 has reached is ceiling of efficacy, and limited pathway targets and aggressive side effects mean that while they have provided a new frontier, investors and innovators are focusing on providing more diversified, safe and long-acting care.
As biopharma diversify to target non GLP-1 responders and improve adherence to provide health weight loss outcomes, they’re exploring novel targets, patient stratification methods and combination therapies to fill the unmet patient need gap that remains.
At the 2nd Obesity & Weight Loss Drug Development Summit Europe, our bespoke partnership opportunities allow you to capitalize on the surge of innovation, investment, and deal activity reshaping obesity therapeutics, and support the companies developing the next generation of market-defining therapies.
Company Type
Why Partner in 2026?
Meet Clients to Build or Expand Your Footprint in Europe
Across the event, our carefully curated audience ensure you access the concentrated, valuable conversations we’re renowned for. Here, every conversation is a dealmaking opportunity with the emerging European leaders set to define the future of obesity and weight loss therapeutics.
Position Yourself at the Epicentre of European Obesity & Weight Loss Innovation
Establish your organisation as a trusted leader in obesity innovation through bespoke branding, thought leadership interviews, and premium visibility across every touchpoint of Europe's premier obesity drug development event.
Demonstrate Your Expertise
Showcase how your solution accelerates asset development to a room of decision-makers actively seeking new partners and demonstrate your value in real time to convert interest into meaningful business opportunities.
Gain the Inside Scoop on Industry Innovations
Stay ahead of the market by securing early visibility into the trends, technologies, and priorities shaping obesity's future, positioning your business to ensure you're ready to grow alongside the next wave of innovation and investment.
Attending Companies in 2025 Included
Hear What Past Sponsors of the Obesity Series Have to Say:
Really great topics and speakers. Energetic networking.
Summit Clinical Research, LLC
Friendly, approachable group with a wide range of expertise and experience.
Antaros Medical AB
Audience Composition
Company Type
Attendee Seniority
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Molly Biggin
Partnerships Director
Obesity Drug Development Summit Europe
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.